SLC18A2 and Parkinson disease: Furthermore, VMAT2 isolated from the striatal terminals from postmortem tissue of Parkinson’s patients shows an impaired rate of dopamine uptake, suggesting that in addition to a loss of VMAT2, the remaining VMAT2 is less efficient at sequestering dopamine16.